We Help Companies Find New Sales Opportunities
We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2013
AstraZeneca is to buy US-based Bristol-Myers Squibb out of their diabetes treatments joint venture for up to £2.5bn, with the transfer of about 4,100 staff.
30-Dec-2013
Ceramic Fuel Cells is to sell its powder plant assets in Bromborough to ICL-PP Europe for £1.2m.
18-Dec-2013
Alliance Pharma has acquired the UK rights to the Lypsyl personal care brand from Novartis for £1.8m.
18-Dec-2013
AM Technology, the chemical manufacturing technology firm, has acquired an 11,000 sq ft unit at Berkeley Court in Runcorn.
16-Dec-2013
Lallemand UK has bought the Oban-based marine biotechnology business of Aquapharm Bio-Discovery out of administration.
16-Dec-2013
GlaxoSmithKline is to invest £200m in the expansion of pharmaceutical plants in Hertfordshire and West Sussex, with the creation of an unspecified number of jobs.
12-Dec-2013
Plymouth University is planning to develop a research and education facility at the AstraZeneca environmental laboratory in Brixham next year.
10-Dec-2013
Venn Life Sciences has acquired Medevol, the Belfast-based clinical trials firm, for up to £0.7m.
10-Dec-2013
Johnson & Johnson is opening offices in Cambridge, Cardiff, Edinburgh, Manchester and Oxford, in order to benefit from university medical research.
10-Dec-2013
University of Birmingham is to open a new £6.8m Biomedical Innovation Hub next summer, in order to provide laboratory and office space for local biomedical firms.
09-Dec-2013
AZ Electronic Materials, the speciality chemicals supplier with a global workforce of 1,100, is to be acquired by Merck of Germany for £1.6bn.
09-Dec-2013
Metalysis is seeking financial support to build a titanium powders plant in Yorkshire, in order to manufacture ink for 3D printing.
05-Dec-2013
GlaxoSmithKline is to invest £25m in the expansion of its pharmaceuticals plant in Montrose, with the creation of 25 jobs.
25-Nov-2013
Bodybuilding Warehouse is to set up a 21,000 sq ft sports supplements warehouse at the Guinness Road Trading Estate in Manchester.
21-Nov-2013
AstraZeneca is to relocate up to 400 research scientists to three temporary sites in Cambridge next year, in preparation for the 2016 opening of its new £330m headquarters.
21-Nov-2013
The University of Sussex is planning a £500m expansion programme, including a new facility for genetics, drug discovery and neuroscience research.
21-Nov-2013
Tissue Regenix has submitted plans to build a new 12,000 sq ft headquarters for its medical technology business at Northminster Business Park in York by the end of next year.
19-Nov-2013
Fine Industries, the Teesside-based chemicals manufacturer with 270 staff, has undergone a £25m management buy-out backed by NorthEdge Capital.
13-Nov-2013
AstraZeneca is to invest £120m in the development of a new Zoladex production facility at its site in Macclesfield by 2017, securing the future of 300 jobs.
12-Nov-2013
Takeda is to expand its pharmaceutical research facilities at the Cambridge Science Park with a new 42,000 sq ft building in 2015.
11-Nov-2013
GlaxoSmithKline is to recruit 140 apprentices over the next two years, including 16 at its pharmaceuticals plant in Barnard Castle.
06-Nov-2013
Sense is to build a £12m charity headquarters at the Life Sciences Economic Zone in Birmingham by 2016, with the relocation of 100 jobs and the creation of 100 new jobs.
31-Oct-2013
Ineos is reopening its petrochemical plant at Grangemouth, as part of an agreement with unions that will involve a £300m investment in a new gas terminal.
28-Oct-2013
Genea Biomedx is to set up a fertility research laboratory at Discovery Park in Sandwich, with the creation of 30 jobs.
28-Oct-2013
DE Group, the Doncaster-based pharmaceutical wholesaler with 300 staff, has undergone a management buy-out backed by RBS Invoice Finance.
23-Oct-2013
Corporate Solutions International is planning to expand the workforce at its Sedgefield-based drug and alcohol testing business from 18 to 80 by 2016.
21-Oct-2013
AstraZeneca is to acquire Spirogen, the London-based drug development firm with 25 staff, for an initial £125m, in order to expand its MedImmune biologics division.
17-Oct-2013
AstraZeneca has announced that its MedImmune biologics research division has acquired Spirogen, the biotechnology firm, for an initial £125m.
15-Oct-2013
Glasgow University has secured a £10m government grant to develop a new clinical research facility for chronic diseases.
14-Oct-2013
Cyprotex is setting up a new drug testing facility at BioHub in Alderley Park, Cheshire.
02-Oct-2013
Hospira is relocating its pharmaceutical delivery business from Leamington Spa to a 26,000 sq ft office at the Horizon facility in Maidenhead.
02-Oct-2013
Ineos is considering plans to invest a further £300m in the development of a new gas terminal at Grangemouth, on the condition that unions agree to some job cuts.
01-Oct-2013
Clinigen Group is looking to create up to 90 jobs at its Burton-based pharmaceuticals business over the next few years.
26-Sep-2013
S&D Sealants has acquired SEAM Sealants of Stourbridge for undisclosed terms, in order to expand its nationwide office network.
25-Sep-2013
Phytopharm is to acquire IXICO, the London-based medical technology and diagnostics firm, in a £5.6m reverse takeover.
24-Sep-2013
Centre for Process Innovation is planning to build a new £25m National Biologics Manufacturing Centre in Darlington, including laboratories and conference facilities.
19-Sep-2013
Acdoco is to relocate its Blackburn-based cosmetics and cleaning products business to a 34,000 sq ft warehouse at Northbank Industrial Estate in Irlam.
19-Sep-2013
Molecular Profiles, the Nottingham-based pharmaceuticals and clinical trials firm with 60 staff, has been acquired by US-based Columbia Laboratories for £16m.
18-Sep-2013
Kent County Council has announced that an undisclosed Indian company is considering plans to set up a pharmaceutical manufacturing facility at Discovery Park in Sandwich, with the creation of more than 200 jobs.
17-Sep-2013
Oxford BioMedica has secured funding of £7.1m to expand its Oxford-based biopharmaceutical manufacturing facilities over the next two years.
16-Sep-2013
GroWell Hydroponics has bought Aquaculture Hydroponics of Sheffield out of administration, saving the five remaining jobs.
12-Sep-2013
UDG is planning to set up a £20m 220,000 sq ft pharmaceutical and healthcare distribution centre at the Castlewood site in Derbyshire, with the creation of an initial 50 jobs.
11-Sep-2013
AstraZeneca has won permission to build a 70,000 sq ft finished formulation facility at its pharmaceutical plant in Macclesfield, with the creation of 36 jobs.
11-Sep-2013
Premaitha Health is planning to double the 12-strong workforce at its Manchester-based biotechnology business, having relocated from Cambridge.
10-Sep-2013
Nitto Denko UK has won permission to expand its rubber and plastics manufacturing plant in Mansfield, with the creation of 30 jobs.
03-Sep-2013
Forensic Science Northern Ireland has won approval to build a new £12m DNA processing laboratory at its Seapark site in Carrickfergus.
21-Aug-2013
Thornton & Ross, the Huddersfield-based pharmaceuticals manufacturer with 440 staff, has been acquired by STADA Arzneimittel of Germany for £221m.
19-Aug-2013
Saint-Gobain is to set up a 64,000 sq ft distribution centre for its International Decorative Surfaces business at Parkhouse Industrial Estate near Newcastle-under-Lyme by the end of the year.
15-Aug-2013
Ineos ChlorVinyls has sold its Runcorn-based packed chlorine business to 2M Group for undisclosed terms.
08-Aug-2013
LKQ Euro has acquired Iris Coatings and five automotive paint distributors with 26 depots for undisclosed terms, in order to expand its Euro Car Parts business.
08-Aug-2013
PolyTherics is to merge with Cambridge-based Antitope to create a combined biopharmaceuticals group backed by Imperial Innovations.
05-Aug-2013
ReNeuron is to relocate its Guildford-based stem cell research business and an initial 25 jobs to an undisclosed site in South Wales over the next two years.
23-Jul-2013
Vindon Healthcare, the Rochdale-based manufacturer of environmental control products for the pharmaceutical industry, is in talks to be acquired by BioScience for £12m.
18-Jul-2013
Imperial College London is linking up with 17 universities and 13 companies to form the £24m SynbiCITE Centre, in order to develop new technologies in synthetic biology.
17-Jul-2013
Syntaxin, the Abingdon-based life sciences company specialising in compounds based on botulinum toxins, has been acquired by Ipsen of France for an initial £24m.
16-Jul-2013
Victrex has won permission from Wyre Council to expand its PEEK chemicals plant in Thornton by 2015, with the creation of up to 20 jobs.
16-Jul-2013
Liverpool School of Tropical Medicine is considering plans to expand its research buildings in Pembroke Place by up to 50,000 sq ft.
10-Jul-2013
AbbVie, the biopharmaceutical company, is setting up a 13,000 sq ft office at the Quantum development in Maidenhead.
10-Jul-2013
Evotec is to transfer the work of 120 staff in its chemistry operations from India to Abingdon, at a cost of up to £3.4m.
10-Jul-2013
Intertek Group has acquired Melbourn Scientific, the Cambridge-based pharmaceutical testing firm with 80 staff.
09-Jul-2013
Immunocore is to expand the 55-strong workforce at its Didcot-based biotechnology business with 25 new jobs this year.
08-Jul-2013
AAH Pharmaceuticals is looking to recruit 50 additional warehouse staff and drivers at its warehouse in Talke, Staffordshire.
02-Jul-2013
The University of Dundee has secured funding of £24m from the Medical Research Council, which will create 20 research jobs in its Protein Phosphorylation & Ubiquitylation Unit.
27-Jun-2013
James Briggs, the Oldham-based chemicals manufacturer with about 200 staff, has undergone a management buy-out backed by Endless.
26-Jun-2013
Orla Protein Technologies has secured funding to expand the workforce at its Newcastle-based life sciences business to 20 by the end of next year.
24-Jun-2013
City Health Care Partnership of Hull has acquired Brocklehurst Chemists, the chain of three pharmacies, for undisclosed terms.
24-Jun-2013
AstraZeneca has confirmed plans to develop a new £330m global headquarters for 2,000 staff at the Cambridge Biomedical Campus by 2016.
19-Jun-2013
Eisai Manufacturing is to invest £8m in the expansion of its pharmaceutical manufacturing plant in Hatfield by summer 2014.
19-Jun-2013
Norbrook Laboratories is to create 400 new jobs at its Newry-based veterinary pharmaceuticals business over the next two years.
18-Jun-2013
Cleveland Biotech, the Stockton-based biotechnology firm with 16 staff, has undergone a £4.4m management buy-out backed by NVM Private Equity.
18-Jun-2013
Everbuild Building Products, the Leeds-based manufacturer of sealants and adhesives with 270 staff, has been acquired by Sika of Switzerland.
18-Jun-2013
Almac Pharma Services is to invest £14m in the expansion of its Armagh-based pharmaceutical manufacturing business, with the creation of 229 jobs.
12-Jun-2013
RelayMed is looking to create at least 20 new jobs at its Edinburgh-based health diagnostics software business over the next two years.
06-Jun-2013
Oxbow has won permission to build a sulphur processing plant at the Western Docks in Southampton, with the creation of 12 jobs.
29-May-2013
Magstim has acquired Seren Medical, the Cardigan-based medical device manufacturer, takes its total workforce to 87.
22-May-2013
Instem has acquired Logos Holdings, the London-based developer of clinical trials software, for up to £5m.
14-May-2013
Redx Pharma is to set up a research and development centre at Alderley Park in Cheshire, with the creation of 120 jobs.
08-May-2013
PRA of the US is planning to double the 100-strong workforce at its clinical research operation in Swansea, having acquired a larger office at the SA1 waterfront development.
08-May-2013
Cerus Endovascular is to relocate from Oxford to the Liverpool Science Park, having secured an investment from the North West Fund for Biomedical to develop an implantable medical device.
07-May-2013
Source BioScience has acquired Inverclyde Biologicals, the Motherwell-based manufacturer of diagnostic kits, for £1.6m.
30-Apr-2013
Eastman is planning to invest tens of millions of pounds in a new plant to manufacture heat transfer fluids at the Solutia site in Newport by 2014, with the creation of 17 jobs.
29-Apr-2013
Beiersdorf is to expand its skin care products warehouse at Holford Industrial Park in Birmingham by 80,000 sq ft, with the creation of 50 jobs.
25-Apr-2013
The Scottish Funding Council is to help fund a £30m investment in three new life science innovation centres in Glasgow and Edinburgh, in order to provide genetic testing services and create up to 2,000 jobs.
24-Apr-2013
Dechra Pharmaceuticals is setting up a new 3,000 sq ft headquarters on the Cheshire Business Park in Northwich.
17-Apr-2013
Cleveland Potash is planning to invest up to £300m in the expansion of its potash mining and transport operations in Boulby and Teesport, with the creation of 220 jobs by 2015.
16-Apr-2013
Life Technologies, the biotechnology firm with more than 500 staff in Renfrewshire, has been acquired by US-based Thermo Fisher Scientific for about £8.9bn.
16-Apr-2013
Brunel Healthcare is seeking permission to expand its nutritional supplements factory in Swadlincote, with the creation of 60 jobs.
08-Apr-2013
Daktari Diagnostics of the US has confirmed plans to set up a £12m medical devices factory in Inverness by next year, with the creation of 126 jobs.
04-Apr-2013
The Welsh Government has announced plans to set up a new Life Sciences Hub in Cardiff Bay later this year, in order to encourage co-operation between academic, business and funding organisations.
20-Mar-2013
Angel Biotechnology has sold its medical collagen operations out of administration to a new Glasgow-based company called Collbio.
19-Mar-2013
Johnson & Johnson is to set up a life sciences innovation centre in London, in order to invest in the UK medical research industry.
18-Mar-2013
GlaxoSmithKline is considering plans to relocate about 250 research and development jobs from Harlow to sites in Ware and Stevenage next year.
13-Mar-2013
York Potash is to recruit 20 engineering apprentices in preparation for its proposed new mine near Whitby.
13-Mar-2013
EKF Diagnostics has acquired 360 Genomics, the diagnostics technology firm, from Oxitec for an initial £1.6m.
05-Mar-2013
Encap Drug Delivery, the Livingston-based pharmaceuticals manufacturer with 60 staff, has been acquired by US-based Capsugel for undisclosed terms.
04-Mar-2013
Daktari Diagnostics of the US is considering plans to set up a new headquarters for its life sciences business in Scotland, which could create 126 jobs.
18-Feb-2013
University of Dundee is to set up a £6.5m infectious diseases research centre, with the creation of 11 jobs.
14-Feb-2013
Alstoe Animal Health, the York-based veterinary pharmaceuticals firm with 20 staff, has been acquired by Sogeval of France for undisclosed terms.
13-Feb-2013
Rosemont, the Leeds-based pharmaceuticals manufacturer with 209 staff, has been sold by CBPE Capital to Perrigo Company of the US for £180m.
12-Feb-2013
University of Dundee has secured funding from the European Innovative Medicines Initiative for a £100m drug discovery project at BioCity Scotland in Newhouse, with the creation of 40 jobs.
11-Feb-2013
Sibelco UK has acquired Viaton Industries, the Derbyshire-based supplier of barite minerals for chemical use with 40 staff, for undisclosed terms.
24-Jan-2013
Almac is to invest £6.5m in the expansion of its pharmaceutical laboratories in Craigavon over the next three years, with the creation of up to 60 jobs.
21-Jan-2013
Cangenix, the Canterbury-based drug discovery firm, has been acquired by Galapagos of Belgium for an initial £1m.
17-Jan-2013
Jeyes is to expand the 250-strong workforce at its Thetford-based cleaning products factory with 30 new jobs.
10-Jan-2013
Redx Oncology is looking to recruit more than 60 scientists and technicians at its Liverpool-based research business.
07-Jan-2013
The Roslin Institute has secured a £10m government grant to set up a livestock improvement centre in Midlothian.
07-Jan-2013
Quotient Bioresearch has sold its bioanalytical sciences division to LGC for undisclosed terms.
03-Jan-2013